Published online May 25, 2016. doi: 10.4253/wjge.v8.i10.409
Peer-review started: August 28, 2015
First decision: September 28, 2015
Revised: March 12, 2016
Accepted: March 17, 2016
Article in press: March 18, 2016
Published online: May 25, 2016
Processing time: 266 Days and 23.4 Hours
Core tip: It is still a major controversial point to do routine screening endoscopy for obese patients before surgery. Many authors suggest doing upper esophagogastroduodenoscopy (EGD) for all patients before bariatric procedures because of the lack of correlation between patient symptoms and EGD findings. On the contrary, many other investigators advocate selective approach for asymptomatic patients because of the relatively weak clinical relevance of the majority of the lesions discovered on routine EGD along with the cost and invasiveness of the EGD. The upper endoscopy is commonly indicated in the postoperative bariatric patient to evaluate post-bariatric symptoms, to detect and manage complications, as well as evaluation of failure of weight loss. Post-bariatric complications prompting upper endoscopy include bleeding, anastomotic or staple line leaks or fistulae, sleeve stricture in laparoscopic sleeve gastrectomy or stomal stenosis in laparoscopic Roux en Y gastric bypass, or laparoscopic minigastric bypass. We aimed in this retrospective study to answer if it is still necessary to do pre-bariatric screening endoscopy and to evaluate the efficacy and safety of the endoscopic therapy for management of post-bariatric complications.
